Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-15
2009-12-08
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S276700
Reexamination Certificate
active
07629356
ABSTRACT:
This invention relates to substituted pyrrolo[3,4-b]pyridinamines having the structural formula IA below:and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.
REFERENCES:
patent: 2006/0281729 (2006-12-01), Iserloh et al.
patent: 2007/0049589 (2007-03-01), Thompson, III et al.
patent: 2007/0099875 (2007-05-01), Zhu et al.
patent: 2007/0099898 (2007-05-01), Zhu et al.
patent: 686673 (1995-06-01), None
patent: 742217 (1996-05-01), None
patent: 99/11643 (1999-03-01), None
patent: 2006/020879 (2006-02-01), None
patent: 2006/076284 (2006-07-01), None
patent: 2006/099379 (2006-09-01), None
patent: 2006/138217 (2006-12-01), None
patent: 2006/138264 (2006-12-01), None
patent: 2006/138265 (2006-12-01), None
patent: 2006/138266 (2006-12-01), None
patent: 2007/011810 (2007-01-01), None
patent: 2007/049532 (2007-05-01), None
patent: 2007/058602 (2007-05-01), None
patent: 2007/146225 (2007-12-01), None
patent: 2007/149033 (2007-12-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, p. 205.
DörwaId, F. Zaragoza. Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, 2005, Preface.
Vippagunta, et al. Advanced Drug Delivery Reviews, 48, 2001, p. 18.
Blanchard, Barbara; PNAS, Oct. 2004, 101 (40), 14326-14332.
Barrett, P et al, J. Chem. Soc., 1939, 1809-20.
Bartlett, R et al, J. Chem. Soc. Section C., 1969, 1, 129-33.
Sawanishi et al, Chemical & Pharmaceutical Bulletin, 1985, 33 (10), 4564-71.
Siling, S et al, Doklady Akademii Nauk SSSR, 1988, 299 (3), 633-5.
De Strooper, Bart et al., A Firm Base for Drug Development, Dec. 1999, Nature 402, 1999, 471-472.
Yankner B A., New Clues to Alzheimer's Disease: Unraveling the Roles of Anyloid and Tau, Nature Medicine, 1996, 2(8), 850-852.
Von Angerer, S. “Product class 12: pyrimidines”, Science of Synthesis, 2004, 16, 379-572.
Chessari Gianni
Congreve Miles Stuart
Holenz Jörg
Murray Christopher
Patel Sahil
Astex Therapeutics
AstraZeneca AB
Gryte David M.
Willis Douglas M
Wilson James O
LandOfFree
Substituted pyrrolo[3,4-b]pyridinamines and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrrolo[3,4-b]pyridinamines and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrrolo[3,4-b]pyridinamines and pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4128451